[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EP0638059A1 - Process for the preparation of 3(s)-methylheptanoic acid and intermediates therefor - Google Patents

Process for the preparation of 3(s)-methylheptanoic acid and intermediates therefor

Info

Publication number
EP0638059A1
EP0638059A1 EP93903682A EP93903682A EP0638059A1 EP 0638059 A1 EP0638059 A1 EP 0638059A1 EP 93903682 A EP93903682 A EP 93903682A EP 93903682 A EP93903682 A EP 93903682A EP 0638059 A1 EP0638059 A1 EP 0638059A1
Authority
EP
European Patent Office
Prior art keywords
acid
methylheptanoic
methylheptanoic acid
methyl
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP93903682A
Other languages
German (de)
French (fr)
Inventor
Charles K-F Chiu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of EP0638059A1 publication Critical patent/EP0638059A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00Separation of optically-active compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42Separation; Purification; Stabilisation; Use of additives
    • C07C51/487Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification

Definitions

  • the present invention is directed to a process and intermediates for the manufacture of 3(S)-methylheptanoic acid of the absolute stereochemical formula (I)
  • R 4 and R 5 are each hydrogen or one of R 4 and R 5 is hydrogen and the other is (C,-C 6 )alkyl or (C 6 -C 8 )cycloalkylmethyl as described in copending, commonly owned United States Patent Applications Serial Nos. 07/346,118, filed February 21 , 1989 and 07/341 ,350 filed February 21 , 1989, which are herein incorporated by reference.
  • Optically pure 3(S)-methylheptanoic acid (I) has been prepared from the corresponding racemate in unspecified yield by multiple (eight) crystallizations of the quinine salt at an inconveniently low temperature of -15°C. [Levene et al., J. Biol. Chem. 95, pp. 1-24, 1932, at page 18, there called 2-n-butylbutyric acid-4].
  • Optically active 3-methylheptanoic acid has subsequently been produced by a number of other methods (Soai et al., J. Chem. Soc, Chem. Commun. 1985, pp. 496-470; Oppolzer et al., Helv. Chim. Acta.
  • the product acid is not optically pure, the reaction temperatures are inconveniently low, between -78° C and -30° C, use of organometallic reagents, which are difficult to handle on a large scale, is required, overall yields are low; and/or the required reagents are not readily available.
  • This invention relates to a novel process for the preparation of 3(S)- methylheptanoic acid which comprises the sequential steps of;
  • step (a) reaction of racemic 3-methylheptanoic acid with (S)-oc-methylbenzyl amine to form a mixture of diastereomeric salts;
  • step (b) separation of the diastereomeric salts from step (a) by recrystallization to yield (S)-oc-methylbenzylammonium 3(S)-methylheptanoate;
  • step (c) conversion of said (S)- ⁇ -methylbenzy ⁇ ammonium 3(S)-methyl heptanoate of step (b) to 3(S)-methylheptanoic acid by treatment with acid.
  • this invention relates to the use of acetonitrile as the recrystallizing solvent in step (b).
  • this invention relates to the compound (S)-cc- methyibenzyIammonium * 3(S)-methyIheptanoate.
  • this invention comprises a process for preparation of 3(S)- methylheptanoic acid from an enriched mixture of 3R and 3S-methylheptanoic acid which contains a preponderance of the (S) isomer.
  • an enriched mixture containing about 70% 3(S)-methylheptanoic acid is available from the procedure of
  • reaction inert solvent refers to a solvent system in which the components do not react with starting materials, reagents, intermediates or products in a manner which adversely affects the yield or purity of the desired product. Racemic 3-methylheptanoic acid is readily available by the procedure of Organic Synthesis, Coll. Vol. 5, 762-766, (John Wiley & Sons, 1973) which is herein incorporated by reference.
  • Racemic 3-methylheptanoic acid is dissolved in a reaction inert solvent and an approximate molar amount of (S)-oc methylbenzylamine is added slowly.
  • the choice of solvent is not critical, but it was found that the diastereomeric salt readily precipitates from acetonitrile which is the preferred solvent.
  • the temperature of the salt formation is not critical, but room temperature was found to be convenient and is preferred.
  • the diastereomeric salt of racemic 3-methylheptanoic acid and (S)-cc- methylbenzylamine is purified by recrystallization to isolate the desired (S)-oc- methylbenzylammonium (S)-3-methylheptanoate which is generally less soluble than the other diastereomeric salt i.e., R-acid/S-amine.
  • Acetonitrile is the preferred solvent for recrystallization. Multiple recrystallizations may be required to obtain the required optical purity and three crystallizations were found to yield a 98% optically pure product. It was found to be convenient to dissolve the salt in boiling solvent and cool slowly over several hours until the product has precipitated.
  • 3(S)-me_hylheptanoic acid is obtained from the salt by acidification of a solution of the salt with strong acid at room temperature.
  • the temperature, solvent and acid are not critical. Any strong mineral acid is effective; hydrochloric acid is preferred.
  • the preferred solvent is a two phase system employing n-hexanes or ethylacetate and water, but any reaction inert solvent system would be acceptable.
  • Example 3 3(S,-Methylheptano.c Acid A.
  • the salt from Example 2 (1.59 g, 5.99 mmol) in a mixture of ethyl acetate (20 mL) and water (10 mL) was treated with 1N HCl (10 mL) and stirred at room temperature for 1.25 hours.
  • the aqueous layer was separated from the organic and extracted with ethyl acetate (20 mL).
  • the organic layer and extract were combined, washed with water (10 mL) and then brine. After drying over sodium sulfate, the solvent was removed to provide the acid as a colorless oil in quantitative yield.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

3(S)-methylheptanoic acid is prepared by fractional crystallization of the salt of racemic 3-methylheptanoic acid with (S)-α-methylbenzyl amine followed by acidification.

Description

PROCESS FOR THE PREPARATION OF 3 (S)-METHYLHEPTANOIC ACID AND INTERMEDIATES THEREFOR *
Background of the Invention The present invention is directed to a process and intermediates for the manufacture of 3(S)-methylheptanoic acid of the absolute stereochemical formula (I)
(I) which is a useful intermediate for the preparation of immunoregulatory agents of the formula (II)
(II) wherein R4 and R5 are each hydrogen or one of R4 and R5 is hydrogen and the other is (C,-C6)alkyl or (C6-C8)cycloalkylmethyl as described in copending, commonly owned United States Patent Applications Serial Nos. 07/346,118, filed February 21 , 1989 and 07/341 ,350 filed February 21 , 1989, which are herein incorporated by reference.
A procedure used to prepare 3(S)-methylheptanoic acid is described by U.S. Serial No. 07/341 ,350 as shown below. TBDΠS
TBDMS
U. S. Serial No. 07/346,118 describes the synthesis of S-3-alkylheptanoic acids from a trans-4-alken-3-ol of the formula (III)
(I") wherein R is methyl or ethyl which is converted to a compound of the formula (IV)
(IV) by the action of t-butyl hydroperoxide, in a reaction inert solvent in the presence of titanium tetraisopropoxide and L-(+)-diisopropyl tartrate, in an amount sufficient to oxidize the S-enantiomer and in a second step, the product of the above reaction is stereospecifically condensed with a trif^^J-alkyljorthoacetate and, without isolation, the intermediate allyl-enol ether rearranged, in the presence of an acid in a reaction inert solvent, to yield a (CT-CaJalkyl 3(R)-alkyl-4-hepenoate of the absolute stereochemical formula (V)
0H
(V) which may be hydrogenated to the desired S-3-alkylheptanoic acid.
Optically pure 3(S)-methylheptanoic acid (I) has been prepared from the corresponding racemate in unspecified yield by multiple (eight) crystallizations of the quinine salt at an inconveniently low temperature of -15°C. [Levene et al., J. Biol. Chem. 95, pp. 1-24, 1932, at page 18, there called 2-n-butylbutyric acid-4]. Optically active 3-methylheptanoic acid has subsequently been produced by a number of other methods (Soai et al., J. Chem. Soc, Chem. Commun. 1985, pp. 496-470; Oppolzer et al., Helv. Chim. Acta. 68, pp. 212-215 (1985); Ohno et al., U.S. Patent 4,564,620 (1986); Mori et al., Synthesis 1982, pp. 752-753; Oppolzer et al., Helva. Chim. Acta. 64, pp. 2808-2811 (1981); Mukaϊyama et al., Chem. Lett. 1981 , pp. 913-916; Posner et al., J. Am. Chem. Soc 103, pp. 2886-2888 (1981); Mukaiyamaet al., Bull. Chem. Soc. Japan, 51 , pp. 3368-3372 (1978); Meyers etal., J. Am. Chem. Soc. 98, pp. 2290-2294 (1976)]. The above described preparations generally suffer from one or more disadvantages: the product acid is not optically pure, the reaction temperatures are inconveniently low, between -78° C and -30° C, use of organometallic reagents, which are difficult to handle on a large scale, is required, overall yields are low; and/or the required reagents are not readily available.
Summary of the Invention
This invention relates to a novel process for the preparation of 3(S)- methylheptanoic acid which comprises the sequential steps of;
(a) reaction of racemic 3-methylheptanoic acid with (S)-oc-methylbenzyl amine to form a mixture of diastereomeric salts; (b) separation of the diastereomeric salts from step (a) by recrystallization to yield (S)-oc-methylbenzylammonium 3(S)-methylheptanoate;
(c) conversion of said (S)-α-methylbenzyΙammonium 3(S)-methyl heptanoate of step (b) to 3(S)-methylheptanoic acid by treatment with acid.
In another aspect, this invention relates to the use of acetonitrile as the recrystallizing solvent in step (b).
In yet another aspect this invention relates to the compound (S)-cc- methyibenzyIammonium*3(S)-methyIheptanoate.
In yet another aspect this invention comprises a process for preparation of 3(S)- methylheptanoic acid from an enriched mixture of 3R and 3S-methylheptanoic acid which contains a preponderance of the (S) isomer. Such an enriched mixture containing about 70% 3(S)-methylheptanoic acid is available from the procedure of
Meyers, et al., J. Am. Chem. Soc, 98f 2290-2294, (1976).
Detailed Description of the Invention As used here, the expression "reaction inert solvent" refers to a solvent system in which the components do not react with starting materials, reagents, intermediates or products in a manner which adversely affects the yield or purity of the desired product. Racemic 3-methylheptanoic acid is readily available by the procedure of Organic Synthesis, Coll. Vol. 5, 762-766, (John Wiley & Sons, 1973) which is herein incorporated by reference.
(S)-oc methylbenzylamine is available from the Aldrich Chemical Co., Milwaukee, WI 53233.
Racemic 3-methylheptanoic acid is dissolved in a reaction inert solvent and an approximate molar amount of (S)-oc methylbenzylamine is added slowly. The choice of solvent is not critical, but it was found that the diastereomeric salt readily precipitates from acetonitrile which is the preferred solvent. The temperature of the salt formation is not critical, but room temperature was found to be convenient and is preferred.
The diastereomeric salt of racemic 3-methylheptanoic acid and (S)-cc- methylbenzylamine is purified by recrystallization to isolate the desired (S)-oc- methylbenzylammonium (S)-3-methylheptanoate which is generally less soluble than the other diastereomeric salt i.e., R-acid/S-amine. Acetonitrile is the preferred solvent for recrystallization. Multiple recrystallizations may be required to obtain the required optical purity and three crystallizations were found to yield a 98% optically pure product. It was found to be convenient to dissolve the salt in boiling solvent and cool slowly over several hours until the product has precipitated. 3(S)-me_hylheptanoic acid is obtained from the salt by acidification of a solution of the salt with strong acid at room temperature. The temperature, solvent and acid are not critical. Any strong mineral acid is effective; hydrochloric acid is preferred. The preferred solvent is a two phase system employing n-hexanes or ethylacetate and water, but any reaction inert solvent system would be acceptable.
The following examples are provided solely for the purpose of further illustration and are not intended to limit the invention which is defined by the claims.
Example 1
Preparation of the Diastereomeric Salt of 3-Methylheptanoic Acid and (S)-oc -Methyl Benzylamine A solution of racemic 3-methylheptanoic acid (3.1 g, 21.5 mmol) in acetonitrile (20 mL) was treated with dropwise addition of (S)-o -methylbenzylamine (2.8 mL, 21.5 mmol).
White solid was observed to precipitate, and the resulting white suspension was stirred at room temperature for 3.5 hours. The white solid was collected by suction filtration and dried in vacuum (house vacuum, 48° C) overnight. 4.65 g of the diastereomeric salt was obtained (82% yield).
Example 2 Recrystallization of the Diastereomeric Salt; (S)--χ-methyΙbenzylammonium 3(S)- methylheptanoate
A slurry of the 3-methylheptanoic acid/(S)-oc -methylbenzylamine salt (30 g) from
Example 1 in acetonitrile (300 mL) was stirred mechanically under nitrogen and heated with an oil bath until complete dissolution was observed. The solution was allowed to cool slowly as white solid precipitated. The resulting suspension was stirred overnight and the white solid was collected by suction filtration. After drying in a vacuum oven, 20.77 g of salt was obtained (37% ee by rotation, [fD 5 =-11.27°, C=5.05,CHCI3). The above procedure was repeated twice to provide 10.98 g of the salt (73% yield of theoretical). The optical purity was judged to be 97%ee ([cc]D =-13.66°, C=5.05, CHC by comparing the rotations of diastereomeric salts from optically pure acid prepared by the method of U.S. Serial No. 07/341 ,350 and the title compound.
Example 3 3(S,-Methylheptano.c Acid A. The salt from Example 2 (1.59 g, 5.99 mmol) in a mixture of ethyl acetate (20 mL) and water (10 mL) was treated with 1N HCl (10 mL) and stirred at room temperature for 1.25 hours. The aqueous layer was separated from the organic and extracted with ethyl acetate (20 mL). The organic layer and extract were combined, washed with water (10 mL) and then brine. After drying over sodium sulfate, the solvent was removed to provide the acid as a colorless oil in quantitative yield.
B. The salt from Example 2 (1.0 g, 3.77 mmol) in a mixture of n-hexanes (10 mL) and water (5 mL) was treated with 1N HCl (5 mL) and stirred at room temperature for 3.5 hourε. The aqueous layer (pH"1) was separated from the organic and extracted with n-hexanes (2x20 mL). The organic layer and extracts were combined, washed with water (10 mL) and then brine. After drying over sodium sulfate, the solvent was removed to provide the acid aε a colorless oil (0.54 g, 99.4% yield).

Claims

1. A proceεε for the preparation of 3(S)-methylheptanoic acid which comprises the sequential steps of: (a) reaction of racemic 3-methylheptanoic acid with (S)-oc -methyl benzylamine to form a mixture of diastereomeric salts;
(b) separation of the diastereomeric salts from step (a) by recrystallization to yield (S)-cc -methyl benzylammonium 3(S)-methylheptanoate;
(c) conversion of said (3)- -methyl benzylammonium 3(S)-methyl heptanoate of step (b) to 3(S)-methylheptanoic acid by treatment with acid.
2. The procesε of claim 1 in which εaid recryεtallization of εtep (b) iε accomplished uεing acetonitrile aε εolvent.
3. The compound (S)- χ -methylbenzyl ammonium 3-(S)-methyiheptanoate.
4. A proceεε for the εeparation of 3(S)-methylheptanoic acid from a mixture of 3(S)- and 3(R)-methylheptanoic acidε which contains a preponderance of 3(S)- methylheptanoic acid which compriεeε the εequential εtepε of:
(a) reaction of εaid mixture of 3-methylheptanoic acidε with (S)-oc- methylbenzylamine to form a mixture of diaεtereomeric εaltε;
(b) separation of the diastereomeric saltε from εtep (a) by recryεtallization to yield (S)-cc -methyl benzylammonium 3(S)-methylheptanoate;
(c) converεion of εaid (S)-α -methyl benzylammonium 3(S)-methyl heptanoate of εtep (b) to 3(S)-methylheptanoic acid by treatment with acid.
EP93903682A 1992-05-01 1993-02-02 Process for the preparation of 3(s)-methylheptanoic acid and intermediates therefor Withdrawn EP0638059A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87756492A 1992-05-01 1992-05-01
US877564 1992-05-01
PCT/US1993/000726 WO1993022269A1 (en) 1992-05-01 1993-02-02 Process for the preparation of 3(s)-methylheptanoic acid and intermediates therefor

Publications (1)

Publication Number Publication Date
EP0638059A1 true EP0638059A1 (en) 1995-02-15

Family

ID=25370235

Family Applications (1)

Application Number Title Priority Date Filing Date
EP93903682A Withdrawn EP0638059A1 (en) 1992-05-01 1993-02-02 Process for the preparation of 3(s)-methylheptanoic acid and intermediates therefor

Country Status (5)

Country Link
EP (1) EP0638059A1 (en)
JP (1) JPH07502538A (en)
CA (1) CA2134093A1 (en)
FI (1) FI945119A (en)
WO (1) WO1993022269A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19501452A1 (en) * 1995-01-19 1996-07-25 Basf Ag Process for the production of optically active 2-halopropionic acids
DE102004025901A1 (en) 2004-05-27 2005-12-22 Consortium für elektrochemische Industrie GmbH Process for the preparation of optically active 3-alkylcarboxylic acids

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB957990A (en) * 1961-03-14 1964-05-13 Merck & Co Inc Salts of substituted indoles
SE363818B (en) * 1968-08-15 1974-02-04 Lilly Co Eli
FR2262652A1 (en) * 1974-02-28 1975-09-26 Rhone Poulenc Ind Resolving optical isomers of cyclonic dicarboxylic acids - by forming salt with alpha-phenyl ethyl amine enantiomer
FR2355797A1 (en) * 1975-09-05 1978-01-20 Wellcome Found PROCESS FOR THE PREPARATION OF SUBSTITUTE VINYLCYCLOPROPANES FOR USE IN THE PREPARATION OF INSECTICIDES
JPH0395188A (en) * 1989-09-08 1991-04-19 Mitsui Petrochem Ind Ltd Continuous production of dimer alkaloids

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9322269A1 *

Also Published As

Publication number Publication date
FI945119A0 (en) 1994-10-31
JPH07502538A (en) 1995-03-16
FI945119A (en) 1994-10-31
WO1993022269A1 (en) 1993-11-11
CA2134093A1 (en) 1993-11-11

Similar Documents

Publication Publication Date Title
GB2025412A (en) Process for manufacturing d camphorate of l carnitinamine and d camphorate of d carnitinamide
FI117438B (en) Process for producing optically enriched bupivacaine
CZ281203B6 (en) Process for preparing optically active amino acid amides, intermediates therefor and use
JP4015696B2 (en) A racemization method for the preparation of piperidine carboxanilide anesthetics similar to levobupivacaine.
US20010000522A1 (en) Racemisation process for use in the manufacture of levobupivacaine and related piperidinecarboxanilide anaesthetic agents
WO1993022269A1 (en) Process for the preparation of 3(s)-methylheptanoic acid and intermediates therefor
EP0182279A1 (en) Process for the optical resolution of racemic mixtures of alpha-naphtyl-propionic acids
US4229593A (en) Method to prepare (+)-cis-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylic acid
US20040235951A1 (en) Process for the production of 9-(Z)-retinoic acid
US6639095B1 (en) Process for preparing optically active α-hydroxy acids and derivatives thereof
JP4030583B2 (en) Stereoselective production of 2-substituted succinic acid derivatives
JP3766463B2 (en) Process for producing enantiomers of 2- (2-fluoro-4-biphenyl) propionic acid
EP1341762A1 (en) Process for resolving racemic mixtures of piperidine derivatives
US7592480B2 (en) Process for producing optically active carboxylic acid
US5688985A (en) Process for producing keto nitrile derivative
US5023365A (en) Process for preparing an intermediate
EP0784608B1 (en) The manufacture of levobupivacaine and analogues thereof from l-lysine
JPH09255668A (en) Production of bisoxazolines
IE66490B1 (en) Process for racemate resolution of 2,2-dimethylcyclopropanecarboxylic acid
US6921832B2 (en) Optically active fluorine-containing compounds and processes for their production
US20040039206A1 (en) Process for resolving racemic mixtures of piperidine derivatives
JPH03261743A (en) Optical resolution of jasmonic acid and dihydrojasmonic acid
JPS6383056A (en) Split of diastereomer
EP0970944B1 (en) Preparation of amino acetic acid esters substituted at position alpha by a tertiary hydrocarbon chain
EP0179487A1 (en) 2-Phenylpropionic acid esters, method for optical resolution thereof and optically active substance thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19941026

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

17Q First examination report despatched

Effective date: 19960301

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 19960409